SCHEMBL14565748

SCHEMBL14565748

CC[C@H](NC=O)C(=O)CNS(=O)(=O)c1ccc(Oc2cccnc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ PKM P14618 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ MMP1 P03956 4/20 0.45
▸ MMP13 P45452 2/20 0.44
▸ MMP2 P08253 2/20 0.44
▸ MMP14 P50281 2/20 0.44
▸ ADAMTS4 O75173 1/20 0.44
▸ MEP1B Q16820 1/20 0.44
▸ ADAMTS5 Q9UNA0 1/20 0.44
▸ TBXAS1 P24557 4/20 0.43
▸ TSHR P16473 2/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ ADAM17 P78536 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ FFAR4 Q5NUL3 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14565746 0.89 MMP2 (0.56) MMP1MMP13MMP2MMP14ADAMTS4
SCHEMBL5445650 0.84 ALDH1A1 (0.48) ALDH1A1PKMHPGDALOX12MMP1
SCHEMBL5445643 0.84 ALDH1A1 (0.51) ALDH1A1PKMHPGDALOX12MMP1
SCHEMBL6557790 0.79 MMP1 (0.50) ALDH1A1PKMHPGDALOX12MMP1
SCHEMBL14378294 0.78 CASP1 (0.48) PKMMMP1MMP13MMP2MMP14
SCHEMBL6557786 0.76 ALDH1A1 (0.48) ALDH1A1PKMHPGDALOX12MMP1
SCHEMBL5445420 0.71 MMP2 (0.61) MMP1MMP13MMP2MMP14ADAMTS4
SCHEMBL5445424 0.71 MMP2 (0.61) ALDH1A1MMP1MMP13MMP2MMP14
SCHEMBL6558732 0.68 MMP1 (0.50) ALDH1A1HPGDMMP1MMP13MMP2
SCHEMBL6558726 0.67 TBXAS1 (0.49) ALDH1A1PKMMMP1MMP13MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196099-B2 Compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2007-03-27 — — US disclosed
Send feedback